| For: | Zhang X, Zhang X, Luo QK, Fu Q, Liu P, Pan CJ, Liu CJ, Zhang HW, Qin T. Pretreatment radiomic imaging features combined with immunological indicators to predict targeted combination immunotherapy response in advanced hepatocellular carcinoma. World J Clin Oncol 2025; 16(4): 102735 [PMID: 40290677 DOI: 10.5306/wjco.v16.i4.102735] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i4/102735.htm |
| Number | Citing Articles |
| 1 |
Wenbo Xie, Linmao Sun, Yumin Fu, Shuhang Liang, Yao Liu, Jiabei Wang, Lianxin Liu. Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Predicting Immunotherapy Response in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Liver Cancer 2026; doi: 10.1159/000550938
|
| 2 |
Lin Fang. Efficacy and immune-inflammatory modulation of combined glucocorticoid and anti-tuberculosis therapy in patients with bronchial asthma and pulmonary tuberculosis. American Journal of Translational Research 2026; 18(4) doi: 10.62347/HRCU4503
|
| 3 |
Zhao Zhan, Dingfang Shi, Rong Huang, Doudou Dong, Lili Zhou, Zichun Ren, Shihua Chen, Mingqiang Lin, Chenqi Xin, Yaobin Lin. PTPN1 synergistically promotes hepatocellular carcinoma progression by inhibiting the expression of STAT5 in CD8+ T cells and enhancing the activity of the PI3K-AKT pathway. International Immunopharmacology 2026; 185 doi: 10.1016/j.intimp.2026.117061
|